v3.26.1
Segment Information (Details 2) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Loss from Operations $ (7,889,900) $ (8,216,400)
Loss from operations before discontinued operations and income taxes (1,775,700) (8,023,600)
Benchtop Laboratory Equipment    
Loss from Operations (412,900) (871,100)
Other income (expense), net 5,263,300 (3,600)
Loss from operations before discontinued operations and income taxes 4,850,400 (874,700)
Corporate and Other    
Loss from Operations (1,349,000) (1,536,800)
Other income (expense), net 114,300 168,700
Loss from operations before discontinued operations and income taxes (1,234,700) (1,368,100)
Consolidated    
Loss from Operations (7,889,900) (8,216,400)
Other income (expense), net 6,114,200 192,800
Loss from operations before discontinued operations and income taxes (1,775,700) (8,023,600)
Bioprocessing Systems Two [Member]    
Loss from Operations (6,128,000) (5,808,500)
Other income (expense), net 736,600 27,700
Loss from operations before discontinued operations and income taxes $ (5,391,400) $ (5,780,800)